|
|
|
11-50 employees
View all
|
|
Biotechnology
|
|
Philadelphia, PA, US
|
|
Enterin Inc. | 821 followers on LinkedIn. Improving the quality of life of patients with neurodegenerative conditions by repairing the gut-brain axis. | Enterin is the first company in the world to develop a novel drug that repairs the dysfunctional gut-brain axis in patients with neurodegenerative disease. We are pioneering the medical community’s understanding of the link between infections, dysfunction of the enteric nervous system (ENS) of the gut, and the early onset and chronic progression of neurodegenerative disease.
Our lead compound, ENT-01 (also known as kenterin), displaces membrane-bound alpha-synuclein (αS) aggregates from nerve cells in the ENS and improves neural signaling between the gut and the brain in preclinical models of Parkinson’s disease.
|
Enterin Inc. Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
75.00%
|
The widely used Enterin Inc. email format is {f}{last} (e.g. [email protected]) with 75.00% adoption across the company.
To contact Enterin Inc. customer service number in your country click here to find.
Michael Zasloff is the CEO of Enterin Inc..
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.